It has emerged as a life-changing option for overweight or obese people who are committed to shedding a significant amount of weight and do not have other significant underlying health issues
In addition, any patients who are overweight or obese are seven times more likely to receive a NAION diagnosis if theyre prescribed Ozempic
Substance-use screening is handled directly: an opt-out exclusionary block flags current alcohol, opioid, or substance-use disorder, and a separate three-month opiate-history field requires free-text date range, name, dose, and frequency before the patient can advance
Consistent weekly dosing optimises blood glucose control and reduces side effects in type 2 diabetes management
Because retatrutide is not yet approved for general prescribing in the UK, all dosing information must be treated as trial-protocol specific